Skip to main content
Premium Trial:

Request an Annual Quote

What Are You Waiting For?

George Church encourages those who can afford genome sequencing to get their genomes done, reports the Boston Globe's Inside the Hive Blog.

Church was hosting some 150 people who had paid about $150 each as part of event put on by Xconomy called Healthcare Gets Personal, and when he asked his audience whether any of them had had their genomes sequence, no one raised their hand, Callum Borchers reports.

"I consider this one of the greatest paradoxes of our time," Church said.

He argued that genome sequencing, though it has yet not realized its promise, can inform people about their risk for a number of diseases, including Tay-Sachs disease and hypertrophic cardiomyopathy. And if there is information that people don't want to know, they can ask for it to be withheld from them.

"I wouldn't wait," he said. "I didn't wait. I was the fifth person on the planet to get sequenced."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.